The administration of antibodies against IL-8 (ABX-IL-8) attenuated the growth of bladder cancer xenograft models [118], and decreased the tumorigenic and metastatic potential of A375SM and TXM-13 melanoma xenograft models [119]. Here, CXCL8 is linked to urinary bladder carcinoma.